Top bipolar disorder research for psychiatrists

In the past year, 2.6% of U.S. adults reported bipolar disorder, according to the NIMH.

Of these, 82.9% were severe cases.

Approximately half of adults with bipolar disorder reported receiving treatment for the disorder in the past year.

Further, 38.8% of those receiving treatment were receiving “minimally adequate” treatment.

Healio/Psychiatry collected the most popular bipolar disorder research in the past year.

Vraylar effective for acute bipolar I depression

Results from an 8-week, multinational, multicenter, randomized, double blind placebo-controlled study indicated consistent efficacy of Vraylar, an atypical antipsychotic currently intended for schizophrenia and bipolar I disorder, for acute bipolar I depression. Read more

Review supports activation as DSM-5 criterion A for bipolar disorder

A systematic review supported the elevation of activation to a criterion A symptom for bipolar disorder in DSM-5. Read more

Latuda safe, well-tolerated for bipolar depression

Results from an extension study indicated Latuda was safe and well-tolerated with minimal effects on weight or metabolic measures among individuals with bipolar depression. Read more

Symptoms may be stronger predictors of bipolar disorder than diagnoses in at-risk youth

Anxiety, depression, affective lability and mania were significant predictors of new-onset bipolar spectrum disorder in youth with familial risk for mood disorders. Read more

Child abuse increases negative outcomes in bipolar disorder

Childhood maltreatment increased risk for negative outcomes in bipolar disorder, according to recent findings. Read more